NCT01440790

Brief Summary

The objective of this study is to determine the effect of reducing the rate of glucose absorption on oxidative stress after eating and to compare it with the effects of vitamin C. The hypothesis is that reducing the rate of glucose absorption will reduce oxidative stress to a similar extent as 1g vitamin C.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2010

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 3, 2011

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 27, 2011

Completed
Last Updated

March 12, 2013

Status Verified

March 1, 2013

Enrollment Period

10 months

First QC Date

August 3, 2011

Last Update Submit

March 11, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incremental Area Under the Curve over 4 hours in serum TRAP (total peroxyl radical-trapping potential)

    Four (4) hours after starting to eat the test meal.

Secondary Outcomes (11)

  • Change over 6 hours from baseline in Plasma glucose

    Baseline and 30, 60, 120, 180, 240, 270, 300 and 360min

  • Change over 6 hours from baseline in Plasma insulin

    Baseline and 30, 60, 120, 180, 240, 270, 300 and 360min

  • Change over 6 hours from baseline in Plasma free-fatty acids

    Baseline and hourly for 6h

  • Change over 6 hours from baseline in Serum vitamin C

    Baseline and 2, 4 and 6h

  • Change over 6 hours from baseline in C-reactive protein

    Baseline and 2, 4 and 6h

  • +6 more secondary outcomes

Study Arms (4)

Glucose bolus alone

PLACEBO COMPARATOR

50g glucose dissolved in water and consumed within 5 minutes.

Dietary Supplement: glucose bolus

Glucose sipping alone

EXPERIMENTAL

50g glucose dissolved in water and consumed gradually over 3 hours.

Dietary Supplement: Glucose sipping

Glucose bolus plus 1g vitamin C

ACTIVE COMPARATOR

50g glucose dissolved in water and consumed in 5 minutes with 1g vitamin C

Dietary Supplement: Glucose bolus plus 1g vitamin C

Glucose sipping plus 1g vitamin C

EXPERIMENTAL

50g glucose dissolved in water and consumed gradually of 3 hours. In addition 1g vitamin C will be taken with the first mouthful of glucose solution.

Dietary Supplement: Glucose sipping plus 1g vitamin C

Interventions

glucose bolusDIETARY_SUPPLEMENT

50g anhydrous glucose dissolved in 300ml water consumed within 10min followed by a lunch (cheese sandwich, fruit and milk) at 4h.

Glucose bolus alone
Glucose sippingDIETARY_SUPPLEMENT

50g anhydrous glucose dissolved in 300ml water consumed at rate of 25ml per 15min followed by a lunch (cheese sandwich, fruit and milk) at 4h.

Glucose sipping alone

50g anhydrous glucose dissolved in 300ml water consumed within 10min with 1g vitamin C followed by a lunch (cheese sandwich, fruit and milk) at 4h.

Glucose bolus plus 1g vitamin C

50g anhydrous glucose dissolved in 300ml water consumed at rate of 25ml per 15min. 1g vitamin C taken with first 25ml. Followed by a lunch (cheese sandwich, fruit and milk) at 4h.

Glucose sipping plus 1g vitamin C

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy males or females
  • to 75 years

You may not qualify if:

  • diabetes
  • recent hospitalization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cardiovascular DiseasesDiabetes Mellitus

Interventions

Ascorbic Acid

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Sugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydrates

Study Officials

  • Thomas MS Wolever, BMBCh PhD DM

    University of Toronto

    PRINCIPAL INVESTIGATOR
  • Shannan Grant, MSc, RD

    University of Toronto

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 3, 2011

First Posted

September 27, 2011

Study Start

August 1, 2010

Primary Completion

June 1, 2011

Study Completion

June 1, 2011

Last Updated

March 12, 2013

Record last verified: 2013-03